Atypical manifestation of carnitine palmitoyltransferase 1A deficiency: hepatosplenomegaly and nephromegaly

J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):e19-22. doi: 10.1097/MPG.0b013e3182a95a42.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carnitine O-Palmitoyltransferase / deficiency*
  • Carnitine O-Palmitoyltransferase / genetics
  • Dietary Carbohydrates / therapeutic use
  • Dietary Supplements
  • Disease Progression
  • Family Health
  • Frameshift Mutation
  • Hepatomegaly / etiology*
  • Humans
  • Hypertrophy
  • Hypoglycemia / diet therapy
  • Hypoglycemia / genetics
  • Hypoglycemia / pathology
  • Hypoglycemia / physiopathology*
  • Infant
  • Kidney / pathology*
  • Lipid Metabolism, Inborn Errors / diet therapy
  • Lipid Metabolism, Inborn Errors / genetics
  • Lipid Metabolism, Inborn Errors / pathology
  • Lipid Metabolism, Inborn Errors / physiopathology*
  • Male
  • Mutation, Missense
  • Republic of Korea
  • Splenomegaly / etiology*
  • Treatment Outcome
  • Triglycerides / chemistry
  • Triglycerides / therapeutic use

Substances

  • Dietary Carbohydrates
  • Triglycerides
  • CPT1A protein, human
  • Carnitine O-Palmitoyltransferase

Supplementary concepts

  • Carnitine palmitoyl transferase 1A deficiency